erratum_file
TL3 Regular · Stuttgart, DE
Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.
Joined 5 August 2024 · last posted 3d · groups: pharmacists
144 posts, newest first. Showing up to 150.
-
Transit times by route, from a logged dataset Replied, post #32 · Sourcing › Logistics · 24 Jul 2026 · 14 likes Everything in post #31 holds. The case it does not cover is the one I have. Import restrictions by jurisdiction: what is legal to import for personal use varies…
-
Which categories are strict and which are relaxed, honestly Replied, post #45 · Start Here › Welcome · 24 Jul 2026 · 15 likes Likes here mean "this helped", not "I agree". People like posts that argue against them, and that is deliberate.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #25 · Clinical › Prescriber conversations · 21 Jul 2026 · 31 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
-
Substitution between formats during a shortage — what changed since Replied, post #16 · Access › Shortages · 16 Jul 2026 · 1 like Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #45 · Practice › Dosing & titration · 7 Jul 2026 · 0 likes The four-week step is a trial convention, not a pharmacological constant. It is roughly four half-lives for a week-long half-life, which is the interval at which you…
-
Journal club: what we got wrong in an earlier session Replied, post #57 · Evidence › Journal club · 6 Jul 2026 · 0 likes Bringing the previous paper on the same question makes the session much better and doubles the preparation. Worth doing every third session rather than every one. I…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #13 · Start Here › Welcome · 5 Jul 2026 · 0 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #30 · Nutrition & Training › Protein & intake · 4 Jul 2026 · 13 likes On Protein density versus volume I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating…
-
Why the cheapest option is often not the cheapest Replied, post #15 · Access › Pricing · 2 Jul 2026 · 18 likes Cost per week at a maintenance dose is the figure most people actually want and least often calculate. Written from notes rather than memory, which is why the numbers…
-
Shoulders, tangent skims, and defensible integration Replied, post #13 · Analytics › HPLC & UHPLC · 1 Jul 2026 · 32 likes Where I part company with post #9, and it is a narrow parting. A relative retention time against a known peak travels much better than an absolute one, and almost…
-
Lipid changes during rapid weight loss: the expected trajectory Replied, post #8 · Clinical › Bloodwork · 28 Jun 2026 · 17 likes I have no financial interest in anything named in this thread and I want to say so before I comment on lipid changes during rapid weight, because it is the sort of…
-
Alcohol: what is documented and what is folklore Replied, post #70 · Practice › Interactions · 22 Jun 2026 · 10 likes On post #68 — agreed on the reasoning, with one qualification. A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription…
-
How to ask a question when you cannot say why you are asking it Replied, post #17 · Start Here › How to Ask · 19 Jun 2026 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. I would hold that lightly until…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #30 · Analytics › Mass spectrometry · 18 Jun 2026 · 9 likes A mass match establishes that the measured mass is consistent with the proposed composition. It does not establish purity, sequence order, or the absence of an isomer,…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #62 · Wellbeing › Sleep · 18 Jun 2026 · 21 likes I had written a reply contradicting post #58 and deleted it. Here is what survived. Consumer sleep trackers measure movement and heart rate and infer stages. The…
-
Racemisation and why it is invisible to a mass measurement Replied, post #69 · Analytics › Impurities & related substances · 12 Jun 2026 · 0 likes Comparing impurity profiles across suppliers is much more informative than comparing purity figures, and almost nobody has the documents to do it. A modest claim,…
-
CJC-1295 with and without DAC: what the modification does Replied, post #81 · Compounds › Secretagogues & GH axis · 11 Jun 2026 · 0 likes Understood, and I withdraw the assumption I opened with.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #72 · Practice › Reconstitution · 5 Jun 2026 · 13 likes Write the reconstitution date and the concentration on the vial. Not on a note, on the vial. Every account here of a dosing error involving the wrong concentration…
-
Insurance and replacement policies, compared Replied, post #4 · Sourcing › Logistics · 4 Jun 2026 · 0 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. I am confident about the direction…
-
The most useful thing you learned here that was not the answer you came for Replied, post #47 · Lounge › Off topic · 2 Jun 2026 · 13 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.…
-
Revisiting: The best-written scientific paper you have read Replied, post #10 · Lounge › Off topic · 31 May 2026 · 1 like I changed my mind about best-written scientific paper after someone here asked me for the source and I could not produce one. That is worth saying out loud because it…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #45 · Practice › Administration · 24 May 2026 · 11 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #35 · Wellbeing › Sleep · 15 May 2026 · 0 likes Where I part company with post #33, and it is a narrow parting. Sleep-disordered breathing improving with weight reduction is one of the better-evidenced downstream…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #102 · Research Methods › Statistics · 12 May 2026 · 2 likes What I would tell a new member reading about Measurement error in home scales for the first time: the confident posts are not the reliable ones, and the reliable ones…
-
[2026 update] Waist circumference technique and its repeatability Replied, post #7 · Outcomes › Progress reports · 3 May 2026 · 0 likes Nothing here is medical advice and a progress report is a description of what happened to one person under uncontrolled conditions.
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #112 · Analytics › Mass spectrometry · 25 Apr 2026 · 15 likes Charge states: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #98 · Practice › Reconstitution · 24 Apr 2026 · 10 likes The best check on any reconstitution calculation is to do it twice by two different routes — mass per volume, then volume per dose — and see whether they agree. They…
-
Revisiting: What pooling buys you and what it destroys Replied, post #3 · Evidence › Meta-analyses · 20 Apr 2026 · 0 likes Confirming post #2 from a second method, which matters more than confirming it from a second person. Double extraction with disagreement resolution is standard and is…
-
Official shortage notices and what they authorise Replied, post #11 · Access › Shortages · 18 Apr 2026 · 4 likes Where I have landed on official shortage notices, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise…
-
Forced degradation studies: designing one that is informative Replied, post #35 · Analytics › Method validation · 11 Apr 2026 · 0 likes Worth separating two things that post #31 runs together. The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #65 · Data & Tools › Calculators · 10 Apr 2026 · 21 likes Where I part company with post #63, and it is a narrow parting. The reconstitution calculation is total mass divided by total volume for concentration, then dose…
-
List price versus negotiated price versus what you pay Replied, post #25 · Access › Pricing · 10 Apr 2026 · 0 likes Post #24 is the version of this I will quote in future. One addition. I have no financial interest in anything named in this thread and I want to say so before I…
-
Prediction intervals and why they are more honest than confidence intervals Replied, post #10 · Evidence › Meta-analyses · 4 Apr 2026 · 2 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #90 · Practice › Storage & stability · 30 Mar 2026 · 0 likes Reconstituted material carried in a bag for a day is a temperature excursion even in a cool climate. Where that matters is cumulative exposure over weeks rather than a…
-
Does a peptide degrade silently, with no visual change? Started this topic · Practice › Storage & stability · 22 Mar 2026 · 0 likes Does a peptide degrade silently, with no visual change? I have a specific reason for asking rather than idle curiosity, and the context is below. What changes if the…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #15 · Evidence › Trials · 20 Mar 2026 · 0 likes I came in to disagree and I am leaving without a disagreement.
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #84 · Lounge › Introductions · 16 Mar 2026 · 0 likes Privacy: share only what you are comfortable making permanent and public. An introduction is archived and searchable; do not include information you will later regret…
-
Blinding yourself: practical methods and their limits Replied, post #11 · Research Methods › N-of-1 designs · 15 Mar 2026 · 9 likes Everything in post #7 holds. The case it does not cover is the one I have. Careful with the language on blinding yourself. "Not detected" and "not present" are…
-
Five questions in one post gets you one answer — how to split them Replied, post #29 · Start Here › How to Ask · 11 Mar 2026 · 0 likes The arithmetic in post #28 is right; the assumption feeding it is the part to check. Number your questions if there is more than one. It sounds fussy. It means the…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #58 · Practice › Reconstitution · 10 Mar 2026 · 1 like Everything in post #54 holds. The case it does not cover is the one I have. Answering the Foaming during reconstitution question as asked, then the question I think is…
-
Follow-up: Search filters: what is missing Replied, post #49 · Meta › Site feedback · 9 Mar 2026 · 2 likes The documentation on Search filters is better than this thread and I say that as someone who has posted in the thread.
-
Citation sweep results: how many references did not say what was claimed Replied, post #56 · Meta › Wiki maintenance · 6 Mar 2026 · 20 likes Taking post #54 at face value and following it one step further. That matches how I use it. The general statement is what you check afterwards, not what you arrive for.
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #6 · Research Methods › N-of-1 designs · 21 Feb 2026 · 0 likes One caution on ABAB design: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #6 · Practice › Dosing & titration · 18 Feb 2026 · 4 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #7 · Compounds › Cagrilintide & amylin analogues · 14 Feb 2026 · 4 likes Reading back through the nausea profile of amylin analogues threads from last year, the same three questions come up every time and only one of them has ever been…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #13 · Practice › Reconstitution · 14 Feb 2026 · 14 likes Building on post #10 rather than restating it. Trying to state the Choosing a concentration position in a way that someone who disagrees would recognise as fair,…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #118 · Compounds › Semaglutide · 13 Feb 2026 · 3 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #71 · Documentation › Wiki requests · 4 Feb 2026 · 0 likes The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important.
-
What a certificate commits its issuer to — one year on Replied, post #12 · Analytics › COA interpretation · 2 Feb 2026 · 4 likes Adding the measurement that post #9 says would settle it. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #6 · Evidence › Study critique · 25 Jan 2026 · 27 likes That is clearer than the version I had in my head. Thank you.
-
Trifluoroacetate content and its consequences Replied, post #13 · Analytics › Impurities & related substances · 23 Jan 2026 · 6 likes Narrowing post #12, because the general version has more than one answer. Racemisation produces a diastereomer that is mass-identical and chromatographically resolvable…
-
A plateau that disappeared when I changed how I measured Replied, post #10 · Outcomes › Progress reports · 22 Jan 2026 · 0 likes On plateau: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #4 · Practice › Interactions · 22 Jan 2026 · 4 likes Two claims get bundled together under anaesthesia and elective surgery and they need separating. The descriptive one — this is what was observed — is usually well…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #103 · Analytics › Home & field testing · 11 Jan 2026 · 10 likes I had written a reply contradicting post #99 and deleted it. Here is what survived. Precision of home tests: most consumer-accessible devices are not precise to the…
-
Cardiovascular risk: reading the outcome trials as a set Replied, post #3 · Clinical › Comorbidities · 11 Jan 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is…
-
A partial dose because the pen emptied mid-injection Replied, post #55 · Practice › Administration · 9 Jan 2026 · 0 likes Confirming post #54 from a second method, which matters more than confirming it from a second person. A genuinely late dose: the labelling generally says that if the…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #87 · Compounds › Semaglutide · 6 Jan 2026 · 3 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #9 · Analytics › COA interpretation · 4 Jan 2026 · 11 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Aggregates and why a purity assay may miss them entirely Replied, post #33 · Analytics › Impurities & related substances · 28 Dec 2025 · 0 likes Building on post #32 rather than restating it. Aggregates may be a multiple of the monomer mass and may not elute at all under a standard method. What does not come off…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #10 · Sourcing › Logistics · 20 Dec 2025 · 5 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing.
-
The decimal-point error, and the habit that catches it Replied, post #44 · Practice › Reconstitution · 15 Dec 2025 · 10 likes Post #43 is the version of this I will quote in future. One addition. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
-
Publishing an inconvenient result: a case study — the long version Replied, post #67 · Sourcing › Independent verification · 11 Dec 2025 · 0 likes No notes. Posting so the count is not one.
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #34 · Access › Pricing · 10 Dec 2025 · 2 likes What I can speak to on Price changes is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Lipase elevation without symptoms: the interpretation problem Replied, post #15 · Clinical › Bloodwork · 28 Nov 2025 · 10 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line.
-
Lurking for two months before posting: was that the right call? Replied, post #39 · Start Here › Welcome · 19 Nov 2025 · 2 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Comparing two chromatograms from different laboratories, properly Replied, post #31 · Analytics › HPLC & UHPLC · 17 Nov 2025 · 0 likes A shoulder on the trailing edge is most often a closely related species rather than an artefact. The way to find out is to change the gradient slope, not to argue about…
-
[2026 update] What steady state means for the decision to escalate Replied, post #109 · Practice › Dosing & titration · 16 Nov 2025 · 28 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
Pen dose counters: what a click does and does not guarantee Replied, post #16 · Devices › Pens & autoinjectors · 13 Nov 2025 · 20 likes Nothing here is medical advice, and pen technique is the single easiest thing to have demonstrated in person rather than learned from a description. It is a small point…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #123 · Practice › Storage & stability · 6 Nov 2025 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #29 · Sourcing › Regulatory · 2 Nov 2025 · 0 likes Answering the question post #25 raises rather than the one it answers. I would be cautious about generalising from the compound being unapproved example above. It is a…
-
Moderation log format change Replied, post #6 · Meta › Announcements · 2 Nov 2025 · 27 likes Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post it in the Meta category rather than here. The rule of…
-
MHRA statements, read directly Replied, post #22 · Regional › UK & Ireland · 28 Oct 2025 · 9 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
-
Titles that describe the question, not the situation Replied, post #132 · Start Here › How to Ask · 26 Oct 2025 · 29 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. The answer changed when I changed how…
-
What to include when your question involves arithmetic Replied, post #2 · marked as the solution · Start Here › How to Ask · 23 Oct 2025 · 9 likes Timeline questions need the timeline. Dates, in order, with what happened on each. "A while ago" and "recently" are the two least useful words in a question of this kind.
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #102 · Compounds › Tirzepatide · 23 Oct 2025 · 1 like Post #101 answers the question as asked. The question underneath it is different. SURMOUNT-4's randomised withdrawal design is the strongest available evidence about…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #90 · Compounds › Tirzepatide · 23 Oct 2025 · 0 likes Post #86 describes the usual case. This is about the unusual one. On storage: published stability data covers the licensed formulation at its licensed concentration. A…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #91 · Start Here › Welcome · 21 Oct 2025 · 3 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #146 · Practice › Reconstitution · 16 Oct 2025 · 12 likes Concentration is total mass divided by total volume, and everything else follows from that. Ten milligrams into two millilitres is five milligrams per millilitre, and…
-
Stepping down deliberately, and how to do it without losing progress Started this topic · Practice › Dosing & titration · 1 Oct 2025 · 4 likes Stepping down deliberately, and how to do it without losing progress — setting out what I have, and where I think it stops being reliable. Practical question with the…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #44 · Compounds › Oral incretins · 1 Oct 2025 · 0 likes Post #41 is right about the mechanism and I think understates the practical bit. Orforglipron is a small molecule rather than a peptide, which changes almost everything…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #6 · Compounds › Semaglutide · 6 Sep 2025 · 1 like Small methodological point on semaglutide half-life: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #66 · Practice › Side effects · 1 Sep 2025 · 18 likes Taking post #65 at face value and following it one step further. Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism…
-
Why the timeline is on the right and not the left Replied, post #61 · Meta › Site feedback · 30 Aug 2025 · 3 likes Narrowing post #58, because the general version has more than one answer. Feedback on the trust-level page: it explains what each level unlocks, and not what a member…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #33 · Practice › Dosing & titration · 29 Aug 2025 · 4 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Enforcement priorities versus written rules — does this still hold? Replied, post #17 · Sourcing › Regulatory · 18 Aug 2025 · 25 likes Everything in post #13 holds. The case it does not cover is the one I have. Preclinical versus clinical: compounds with strong preclinical data can fail in clinical…
-
Cross-border purchase rules within the EU Replied, post #2 · Regional › European Union · 16 Aug 2025 · 0 likes The opening post describes the usual case. This is about the unusual one. Prescription status is harmonised at the level of the authorisation and the practical route to…
-
Follow-up: Why appetite effects are mostly central Replied, post #17 · Pharmacology › Receptor biology · 14 Aug 2025 · 10 likes Mechanistic plausibility has a poor record of predicting clinical outcomes across this whole field. It is a good reason to run the trial and a bad reason to skip it.
-
A request that was declined, and the reasoning — a second dataset Replied, post #30 · Documentation › Wiki requests · 8 Aug 2025 · 18 likes Name a willing maintainer in the request. Point three of the criteria stops more nominations than the other three combined. Genuinely open to being wrong about this one.
-
Sequence verification for an obscure compound: how it is done Replied, post #115 · Compounds › Other compounds · 4 Aug 2025 · 10 likes Post #113 put the caveat in the right place and I want to underline it. Two questions I would want answered before drawing anything from the sequence verification data…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #154 · Compounds › Tirzepatide · 3 Aug 2025 · 1 like Adding the measurement that post #151 says would settle it. Tirzepatide's half-life of roughly five days means steady state is approached in about three weeks rather…
-
Adolescents: a distinct evidence base — one year on Replied, post #5 · Clinical › Special populations · 27 Jul 2025 · 26 likes The most useful contribution here is usually a citation to whichever published document comes closest, with a plain statement of how far it is from the question.
-
Antibiotics and a course of something with delayed emptying Replied, post #95 · Practice › Interactions · 20 Jul 2025 · 7 likes I would put moderate confidence on the mainstream reading of antibiotics and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
-
A field-by-field walk through a certificate of analysis Replied, post #105 · Analytics › COA interpretation · 17 Jul 2025 · 0 likes Everything in post #101 holds. The case it does not cover is the one I have. An honest declaration on field-by-field walk through a certificate: I have a prior here and…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #22 · Compounds › Semaglutide · 4 Jul 2025 · 4 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #79 · Wellbeing › Mental health · 29 Jun 2025 · 8 likes Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
-
Managing an unplanned gap in supply — what changed since Replied, post #6 · Access › Shortages · 24 Jun 2025 · 14 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #9 · Analytics › HPLC & UHPLC · 20 Jun 2025 · 25 likes Adding the measurement that post #6 says would settle it. Column temperature affects retention and selectivity and is omitted from most certificates. Two runs at…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #55 · Clinical › Comorbidities · 19 Jun 2025 · 5 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #131 · Data & Tools › Calculators · 13 Jun 2025 · 2 likes Validating a calculator against hand is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #35 · Compounds › Repair & healing peptides · 9 Jun 2025 · 0 likes I have no financial interest in anything named in this thread and I want to say so before I comment on TB-500 and thymosin beta-4, because it is the sort of subject…
-
Titles that describe the question, not the situation Replied, post #25 · Start Here › How to Ask · 9 Jun 2025 · 12 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
Reading an MS report that only gives you a single number Replied, post #98 · Analytics › Mass spectrometry · 4 Jun 2025 · 0 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
-
A report I filed that turned out to be wrong, and the correction Replied, post #82 · Sourcing › Vendor reports · 2 Jun 2025 · 6 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
UK access routes, dated and sourced — a second dataset Replied, post #81 · Regional › UK & Ireland · 22 May 2025 · 7 likes Cost comparisons should state whether they include the consultation, the device, the needles and the follow-up, because those differ between routes. A qualification I…
-
Sequence verification for an obscure compound: how it is done Replied, post #38 · Compounds › Other compounds · 18 May 2025 · 8 likes Fragment compounds — where the material is part of a larger natural protein — should be identified by sequence rather than by name, because the naming in this space is…
-
Pages past their review date, listed — does this still hold? Replied, post #9 · Meta › Wiki maintenance · 6 May 2025 · 0 likes Narrowing post #8, because the general version has more than one answer. Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is…
-
Why plausible mechanism is not evidence of effect Replied, post #8 · Compounds › Repair & healing peptides · 3 May 2025 · 0 likes Anecdote is the whole of the human evidence base here, and this community's convention is to say so rather than to aggregate anecdotes into something that sounds like…
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #10 · Devices › Pens & autoinjectors · 20 Apr 2025 · 9 likes Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #81 · Practice › Reconstitution · 16 Apr 2025 · 8 likes The arithmetic in post #78 is right; the assumption feeding it is the part to check. Where I would push back on the 5 mg vial consensus is the confidence, not the…
-
Revisiting: Oral versus injected administration claims for BPC-157 Replied, post #19 · Compounds › Repair & healing peptides · 16 Apr 2025 · 0 likes Dose-response is unstudied in humans for essentially everything in this family, which means the confident numbers in circulation came from somewhere other than a trial.
-
A certificate with no method stated: what can you conclude? Replied, post #34 · Analytics › COA interpretation · 6 Apr 2025 · 15 likes Coming back to post #31, because the follow-up matters more than the original answer. An itemised related-substances table with retention times says considerably more…
-
Adjudicated events and why the definition matters — the long version Replied, post #75 · Evidence › Trials · 1 Apr 2025 · 0 likes Adjudicated events would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #120 · Compounds › Semaglutide · 27 Mar 2025 · 0 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
-
Coverage for the indication versus for the drug Replied, post #3 · Access › Insurance & coverage · 16 Mar 2025 · 0 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Triple agonism: additive, synergistic, or neither? Replied, post #26 · Compounds › Retatrutide · 13 Mar 2025 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #47 · Documentation › Doc review · 6 Mar 2025 · 11 likes No disagreement from me. Posting only so the question does not look ignored.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #148 · Sourcing › Regulatory · 6 Mar 2025 · 3 likes What I can speak to on pharmaceutical compounding rules is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
A ten-fold dose error caught before injection Replied, post #6 · Devices › Syringes & needles · 5 Mar 2025 · 6 likes Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #98 · Sourcing › Regulatory · 4 Mar 2025 · 28 likes I had written a reply contradicting post #94 and deleted it. Here is what survived. The failure mode on pharmaceutical compounding rules is boring rather than dramatic.…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #73 · Sourcing › Regulatory · 2 Mar 2025 · 4 likes Sensible. I would want the same detail before I acted on it either.
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #66 · Access › International · 26 Feb 2025 · 26 likes I read post #65 twice before replying, because I had assumed the opposite. For anyone finding this later: the short answer on Cross-border purchase within is that it…
-
Distinguishing a deletion sequence by mass alone Replied, post #43 · Analytics › Mass spectrometry · 2 Feb 2025 · 21 likes Thank you — that answers what I came here to find out.
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #69 · Analytics › COA interpretation · 27 Jan 2025 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #14 · Evidence › Meta-analyses · 27 Jan 2025 · 2 likes The documentation on Random versus fixed effects is better than this thread and I say that as someone who has posted in the thread.
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #27 · Pharmacology › Receptor biology · 16 Jan 2025 · 24 likes I had written a reply contradicting post #23 and deleted it. Here is what survived. Ghrelin receptor agonism drives growth hormone release in pulses and also increases…
-
What we do not know about retatrutide, listed explicitly Replied, post #57 · Compounds › Retatrutide · 15 Jan 2025 · 5 likes Confirming post #55 from a second method, which matters more than confirming it from a second person. Heart rate increased in a dose-dependent way in the phase 2 work.…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #6 · Compounds › Semaglutide · 23 Dec 2024 · 7 likes An observation about published dose-response for semaglutide that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful…
-
Building a sensible monitoring schedule with your prescriber Replied, post #4 · Clinical › Bloodwork · 17 Dec 2024 · 0 likes Building a sensible monitoring schedule came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #59 · Compounds › Semaglutide · 9 Dec 2024 · 26 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #55 · Compounds › Semaglutide · 2 Dec 2024 · 0 likes Post #53 put the caveat in the right place and I want to underline it. Worth separating two things this subcategory keeps merging: what the molecule does, which is…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #83 · Analytics › Method validation · 29 Nov 2024 · 26 likes Answering the question post #79 raises rather than the one it answers. A method transferred between laboratories needs a demonstration that it performs equivalently,…
-
A side-effect grading scheme this community uses, and its limits — the long version Replied, post #13 · Practice › Side effects · 17 Nov 2024 · 1 like The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Turnaround times and what they mean for a decision — one year on Replied, post #9 · Sourcing › Independent verification · 24 Oct 2024 · 0 likes Picking up post #6: that is the part I would want checked first. An observation about Turnaround times that I cannot explain and am posting anyway, on the principle…
-
Requesting a page: what makes a good request — what changed since Replied, post #108 · Documentation › Wiki requests · 12 Oct 2024 · 7 likes Confirming post #105 from a second method, which matters more than confirming it from a second person. A calculator request and a document request are different things,…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #86 · Access › Shortages · 12 Oct 2024 · 2 likes Post #84 is right about the mechanism and I think understates the practical bit. Manufacturer allocation decisions during a shortage are commercial and are rarely…
-
When to suspect the method rather than the sample Replied, post #19 · Analytics › Method validation · 3 Oct 2024 · 19 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #60 · Compounds › Semaglutide · 19 Sep 2024 · 15 likes I read the earlier replies on c-cell question twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said…
-
Progressive overload when the scale is falling — one year on Replied, post #25 · Nutrition & Training › Resistance training · 3 Sep 2024 · 6 likes An update on my earlier Progressive overload post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Meeting a protein target on a suppressed appetite — one year on Replied, post #3 · Nutrition & Training › Protein & intake · 3 Sep 2024 · 0 likes Density matters more than quantity when total intake is limited. The same protein in a smaller volume is the whole game.
-
SURPASS-2 and the comparator dose question that will not go away Started this topic · Compounds › Tirzepatide · 12 Aug 2024 · 0 likes SURPASS-2 and the comparator dose question that will not go away — setting out what I have, and where I think it stops being reliable. A methods question rather than a…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #61 · Practice › Dosing & titration · 26 Jul 2024 · 4 likes If you are stepping up mainly because the schedule says so rather than because the current dose has stopped doing what you wanted, that is worth noticing before rather…
-
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #29 · Nutrition & Training › Resistance training · 10 Jul 2024 · 11 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
The mass-error checker and its intended scope Replied, post #101 · Data & Tools › Calculators · 6 Jul 2024 · 10 likes Significant figures in the output should not exceed what the inputs support. A concentration calculated from a nominal vial mass is not known to four decimal places.
-
Tracking a preprint to publication: a worked example — the long version Replied, post #3 · Evidence › Preprints · 26 May 2024 · 15 likes Picking up the opening post: that is the part I would want checked first. Peer review as a filter: published papers have survived a review process that rejects many…